ANDREW MURPHY - 14 Feb 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research
Signature
/s/**Andrew Murphy
Issuer symbol
REGN
Transactions as of
14 Feb 2022
Net transactions value
-$4,485,614
Form type
4
Filing time
16 Feb 2022, 15:18:03 UTC
Previous filing
14 Dec 2021
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1,791,300 +10,000 +17% $179.13* 68,470 14 Feb 2022 Direct F1
transaction REGN Common Stock Tax liability $4,049,063 -6,460 -9.4% $626.79 62,010 14 Feb 2022 Direct F1
transaction REGN Common Stock Sale $61,587 -99 -0.16% $622.09 61,911 15 Feb 2022 Direct F1, F2
transaction REGN Common Stock Sale $31,295 -50 -0.08% $625.90 61,861 15 Feb 2022 Direct F1
transaction REGN Common Stock Sale $263,761 -421 -0.68% $626.51 61,440 15 Feb 2022 Direct F1, F3
transaction REGN Common Stock Sale $395,319 -630 -1% $627.49 60,810 15 Feb 2022 Direct F1, F4
transaction REGN Common Stock Sale $326,882 -520 -0.86% $628.62 60,290 15 Feb 2022 Direct F1, F5
transaction REGN Common Stock Sale $335,444 -533 -0.88% $629.35 59,757 15 Feb 2022 Direct F1, F6
transaction REGN Common Stock Sale $273,598 -434 -0.73% $630.41 59,323 15 Feb 2022 Direct F1, F7
transaction REGN Common Stock Sale $116,859 -185 -0.31% $631.67 59,138 15 Feb 2022 Direct F1, F8
transaction REGN Common Stock Sale $182,853 -289 -0.49% $632.71 58,849 15 Feb 2022 Direct F1, F9
transaction REGN Common Stock Sale $139,379 -220 -0.37% $633.54 58,629 15 Feb 2022 Direct F1, F10
transaction REGN Common Stock Sale $100,874 -159 -0.27% $634.43 58,470 15 Feb 2022 Direct F1, F11
holding REGN Common Stock 4,269 14 Feb 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,000 -25% $0.000000 30,000 14 Feb 2022 Common Stock 10,000 $179.13 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F10 Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F11 Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
F12 The stock option award vests in four equal annual installments, commencing one year after the date of grant.